Brandon M Lehrich1, Khodayar Goshtasbi2, Frank P K Hsu3, Edward C Kuan4,5. 1. Medical Scientist Training Program, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA, USA. 2. Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, 101 The City Drive South, Orange, CA, 92868-3201, USA. 3. Department of Neurological Surgery, University of California, Irvine, Orange, CA, USA. 4. Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, 101 The City Drive South, Orange, CA, 92868-3201, USA. eckuan@uci.edu. 5. Department of Neurological Surgery, University of California, Irvine, Orange, CA, USA. eckuan@uci.edu.
Abstract
PURPOSE: This study uses a large-population national database to describe the presenting clinical, sociodemographic, treatment, and clinical outcome differences between pediatric and adult craniopharyngiomas. METHODS: This study utilized the 2004-2015 National Cancer Database and was queried for all cases of craniopharyngioma. Multivariate Cox proportional-hazards analysis was used to determine clinical and sociodemographic factors associated with mortality. Kaplan-Meier log-rank test determined differences in overall survival (OS) time. RESULTS: The cohort consisted of 3638 patients, with 816 (22.4%) pediatric (≤ 18 years) patients. Pediatric patients presented with significantly higher frequency of large tumors (> 3 cm, 54.1 vs. 31.8%, p < 0.001), lower frequency of papillary subtype (0.9 vs. 11.5%, p < 0.001), and were exclusively treated at academic centers (100 vs. 73.4%, p < 0.001). Pediatric patients had significantly higher rates of adjuvant radiation (34.3 vs. 22.3%; p < 0.001), and had significantly lower 90-day mortality (1.6 vs. 4.9%; p < 0.001); however, no significant differences in extent of resection (p = 0.93), length of hospital stay (p = 0.53), and 30-day readmissions (p = 0.06) were observed between pediatric and adult patients. On Kaplan-Meier log-rank test, there were no significant differences in OS in pediatric patients receiving gross total resection (GTR), subtotal resection (STR), or STR + adjuvant radiation (p = 0.68). Lastly, when comparing endoscopic and open surgical approaches in pediatric patients, there were no significant differences in extent of surgical resection (p = 0.81), length of hospital stay (p = 0.54), 30-day readmissions (p = 0.22), and 90-day mortality (p = 0.80). CONCLUSION: Craniopharyngioma has improved OS in pediatric compared to adult patients. Pediatric craniopharyngioma patients are best managed within multidisciplinary teams at academic centers with an individualized approach.
PURPOSE: This study uses a large-population national database to describe the presenting clinical, sociodemographic, treatment, and clinical outcome differences between pediatric and adult craniopharyngiomas. METHODS: This study utilized the 2004-2015 National Cancer Database and was queried for all cases of craniopharyngioma. Multivariate Cox proportional-hazards analysis was used to determine clinical and sociodemographic factors associated with mortality. Kaplan-Meier log-rank test determined differences in overall survival (OS) time. RESULTS: The cohort consisted of 3638 patients, with 816 (22.4%) pediatric (≤ 18 years) patients. Pediatric patients presented with significantly higher frequency of large tumors (> 3 cm, 54.1 vs. 31.8%, p < 0.001), lower frequency of papillary subtype (0.9 vs. 11.5%, p < 0.001), and were exclusively treated at academic centers (100 vs. 73.4%, p < 0.001). Pediatric patients had significantly higher rates of adjuvant radiation (34.3 vs. 22.3%; p < 0.001), and had significantly lower 90-day mortality (1.6 vs. 4.9%; p < 0.001); however, no significant differences in extent of resection (p = 0.93), length of hospital stay (p = 0.53), and 30-day readmissions (p = 0.06) were observed between pediatric and adult patients. On Kaplan-Meier log-rank test, there were no significant differences in OS in pediatric patients receiving gross total resection (GTR), subtotal resection (STR), or STR + adjuvant radiation (p = 0.68). Lastly, when comparing endoscopic and open surgical approaches in pediatric patients, there were no significant differences in extent of surgical resection (p = 0.81), length of hospital stay (p = 0.54), 30-day readmissions (p = 0.22), and 90-day mortality (p = 0.80). CONCLUSION:Craniopharyngioma has improved OS in pediatric compared to adult patients. Pediatric craniopharyngiomapatients are best managed within multidisciplinary teams at academic centers with an individualized approach.
Entities:
Keywords:
Craniopharyngioma; Endoscopic; NCDB; National Cancer Database; Pediatrics; Skull base
Authors: Abd El Rahman Enayet; Mostafa M E Atteya; Hala Taha; Mohamed Saad Zaghloul; Amal Refaat; Eslam Maher; Amal Abdelaziz; Mohamed A El Beltagy Journal: Childs Nerv Syst Date: 2020-07-26 Impact factor: 1.475
Authors: Chi Zhang; Vivek Verma; Elizabeth R Lyden; David P Horowitz; Brad E Zacharia; Chi Lin; Eileen P Connolly Journal: Am J Clin Oncol Date: 2018-08 Impact factor: 2.339
Authors: Tanner K Hill; Michael J Baine; Vivek Verma; Morshed Alam; Elizabeth R Lyden; Chi Lin; Eileen P Connolly; Chi Zhang Journal: Anticancer Res Date: 2019-02 Impact factor: 2.480
Authors: Yuan J Rao; Comron Hassanzadeh; Benjamin Fischer-Valuck; Michael R Chicoine; Albert H Kim; Stephanie M Perkins; Jiayi Huang Journal: J Neurooncol Date: 2016-12-23 Impact factor: 4.130
Authors: Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Kurtis I Auguste; Nalin Gupta Journal: J Neurosurg Pediatr Date: 2012-08-24 Impact factor: 2.375
Authors: Annie Drapeau; Patrick C Walz; Jacob G Eide; Alex J Rugino; Ammar Shaikhouni; Ahmed Mohyeldin; Ricardo L Carrau; Daniel M Prevedello Journal: Childs Nerv Syst Date: 2019-08-05 Impact factor: 1.475